logo
  

Kennametal Accelerates Structural Cost Reduction Plans - Quick Facts

Kennametal Inc. (KMT) announced Tuesday that it is continuing cost-control actions to mitigate the lower market conditions associated with COVID-19.

The compensation of salaried employees will temporarily be reduced by 10 to 20 percent based on job level through the first half of fiscal 2021. This action is expected to save approximately $10 million to $15 million per quarter.

The Company will continue temporary shutdowns and reduced production schedules to align manufacturing capacity to anticipated customer demand. Its Board of Directors cash compensation will be reduced by 20 percent through the first half of fiscal 2021.

The company also provided an update on its ongoing Simplification/Modernization initiative. It is accelerating its structural cost reduction plans with a restructuring of approximately 10 percent of salaried employees globally, which is expected to be substantially complete in the first half of fiscal 2021.

The Company is also increasing the estimated annualized benefits of its fiscal 2021 Restructuring Actions to $65 million to $75 million from $25 million to $30 million and the pre-tax charges to $90 million to $100 million from $55 million to $60 million.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The five-day holiday shopping period from Thanksgiving Day through Cyber Monday saw about 180 million Americans making in-store and online purchases, according to the National Retail Federation's Annual Thanksgiving Weekend Consumer Survey, conducted by Prosper Insights & Analytics. The shoppers spent an average of $301.27 on holiday-related purchases such as gifts, décor, apparel and toys. Biopharmaceutical company Immunome, Inc. (IMNM) announced Wednesday that it has conducted an assessment of the reported mutations in the new SARS-CoV-2 variant, Omicron (B.1.1.529). Based upon structural mapping of those mutations and activity against previous and current CDC variants of concern,... CVS Health said it has installed time delay safe technology in all 392 Illinois CVS Pharmacy locations, including those in Target stores, to help reduce organized retail crime. The installation of new safes for controlled substances are anticipated to help prevent pharmacy robberies. There is also potential for associated diversion of controlled substance medications, including opioid medications.
RELATED NEWS
Follow RTT